Johnson & Johnson
$262.51Change from previous close: −0.84%Absolute change: −$2.23
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $633.32B
- Enterprise value
- $666.27B
- P/E (trailing 12 months)
- 30.5
- Forward P/E
- 21.7
- PEG
- 2.81
- Price/book
- 7.45
- Price/sales
- 6.47
- EV/EBITDA
- 19.1
- EV/revenue
- 6.80
Profitability and growth
- Gross margin
- 68.1%
- Operating margin
- 29.2%
- Net margin
- 21.5%
- ROE
- 25.7%
- ROA
- 8.6%
- Revenue growth (year over year)
- 6.6%
- Earnings growth (year over year)
- -0.9%
Financial health
- Total cash
- $20.76B
- Total debt
- $49.04B
- Debt/equity
- 0.58
- Current ratio
- 1.09
- Quick ratio
- 0.73
Dividends
- Annual dividend per share
- $5.36
- Dividend yield
- 2.0%
- Payout ratio
- 60.8%
- Ex-dividend date
- August 25, 2026
Analysts and estimates
- Average price target
- $279.27
- Median price target
- $283.50
- High price target
- $320.00
- Low price target
- $190.00
- Number of analysts
- 22
- Consensus
- Buy
- Forward EPS
- $12.14
- EPS estimate, current year
- $11.08
Shares and trading
- Beta
- 0.24
- Average volume
- 6.97M
- Shares outstanding
- 2.41B
- Float
- 2.41B
- Institutional ownership
- 76.7%
- Insider ownership
- 0.1%
- Short interest (% of float)
- 1.0%
- Short ratio (days)
- 3.42